# EDGAR Filing Document

**Accession Number:** 0001786767
**File Stem:** 0001193805-26-000116
**Filing Date:** 2026-2
**Character Count:** 69077
**Document Hash:** effbe7c763fcc35c11b6ba77c6957679
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193805-26-000116.hdr.sgml**: 20260209

**ACCESSION NUMBER**: 0001193805-26-000116

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 8

**FILED AS OF DATE**: 20260209

**DATE AS OF CHANGE**: 20260209

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** WEX Inc.
- **CENTRAL INDEX KEY:** 0001309108
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 010526993
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-80578
- **FILM NUMBER:** 26609723

**BUSINESS ADDRESS:**
- **STREET 1:** 1 HANCOCK STREET
- **CITY:** PORTLAND
- **STATE:** ME
- **ZIP:** 04101
- **BUSINESS PHONE:** (207) 773-8171

**MAIL ADDRESS:**
- **STREET 1:** 1 HANCOCK STREET
- **CITY:** PORTLAND
- **STATE:** ME
- **ZIP:** 04101

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Wright Express CORP
- **DATE OF NAME CHANGE:** 20041118
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Impactive Capital LP
- **CENTRAL INDEX KEY:** 0001786767

**ORGANIZATION NAME:**
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 450 WEST 14 STREET
- **STREET 2:** 12TH FLOOR
- **CITY:** NEW YORK CITY
- **STATE:** NY
- **ZIP:** 10014
- **BUSINESS PHONE:** (212) 218-8810

**MAIL ADDRESS:**
- **STREET 1:** 450 WEST 14 STREET
- **STREET 2:** 12TH FLOOR
- **CITY:** NEW YORK CITY
- **STATE:** NY
- **ZIP:** 10014

## Ex-1

Exhibit 1

**<u>Transaction in the Shares of the Issuer During the Past Sixty Days</u>**

---

| | | | |
|:---|:---|:---|:---|
| <u>Nature of the Transaction</u> | Amount of Securities<br> <u>Purchased/(Sold)</u> | <u>Price ($)</u> | Date of<br> <u>Purchase/Sale</u> |

---

**<u>IMPACTIVE CAPITAL LP<br> (through the Impactive Funds)</u>**

---

| | | | |
|:---|:---|:---|:---|
| Sale of Common Stock | (1200) | 155.0496 | 02/02/2026 |
| Sale of Common Stock | (154403) | 149.3608 | 02/04/2026 |
| Sale of Common Stock | (182397) | 148.4366 | 02/05/2026 |
| Sale of Common Stock | (150000) | 154.669 | 02/06/2026 |

---

## Exhibit 99.1

Exhibit 99.1

![](image_001.jpg)

**Impactive Capital Nominates Four Candidates to WEX Board** 

*Contends Board Level Change is Required to Address Alarming Share Price Underperformance, Culture of Entrenchment and Widening Valuation Gap Versus Its Closest Peer*

*Nominees Kurt Adams, Ellen Alemany, Ken Cornick and Lauren Taylor Wolfe Each Bring an Owner's Perspective and the Relevant Industry Experience to Strengthen Strategic Oversight, Enhance Capital Allocation and Improve Operational Performance*

*Nominees Have Demonstrated Conviction in WEX's Value Potential and Personally Purchased More Shares Than the Entire Incumbent Board Over the Past Nine Years*

**New York, NY – February 9, 2026 –** Impactive Capital, LP, ("Impactive" or "we") together with its affiliates, one of the largest shareholders of WEX Inc. (NYSE: WEX) (the "Company" or "WEX") with an ownership interest of approximately 5.0%, today announced that it has nominated four candidates – Kurt Adams, Ellen Alemany, Ken Cornick and Lauren Taylor Wolfe – for election to the WEX Board of Directors (the "Board") at the upcoming 2026 annual meeting of stockholders (the "annual meeting").

Impactive issued the following statement:

"As one of WEX's largest and most committed investors, Impactive is fully aligned with the success of the Company. This is why for the past four years we have repeatedly sought to engage constructively with the Board to help close the gap between WEX's intrinsic value and its stock price. Despite our best efforts, the Board has continued to dismiss our view that WEX's long-term owners deserve meaningful representation in the boardroom to hold management accountable and drive improved operating performance. Without oversight by shareholders, the outcomes have been both predictable and deeply disappointing, and the widening gap versus its closest peer, Corpay, Inc. (NYSE: CPAY), is increasingly alarming. Over the last five years, WEX has trailed Corpay by 58% and underperformed the S&P MidCap 400 by 76%.<sup>1</sup> More recently, over the past three years, it has underperformed Corpay by 81% and the S&P MidCap 400 by 52%.

![](image_002.jpg)

------

<sup>1</sup> Source: FactSet. Total shareholder returns with dividends reinvested as of February 6, 2026.

Shareholders have spent years calling on the Board to implement steps such as holding management accountable for returns on internal and external investments, disciplined pricing, cost efficiency and business simplification to improve returns and unlock shareholder value. Instead, the Board has pursued M&A with questionable strategic fit, adding cost and complexity, and approved internal investments that have not generated any quantifiable returns. These failures have had a tangible impact: WEX's operating margins trailed its closest peer Corpay by over 18 points in 2025, and the gap has only been widening.<sup>2</sup> Since 2024, management has celebrated the "success" of sales and marketing investments, despite WEX delivering 80% lower organic growth and half the operating margins of Corpay. The Board's prolonged failure to hold management accountable has allowed underperformance to become the status quo.

After we raised our concerns publicly and disclosed our intention to vote against three directors at the 2025 annual meeting, shareholders delivered a clear vote of no confidence. CEO and Chair Melissa Smith and two other incumbent directors, including the outgoing Lead Independent Director, were rejected by over 30% of voting shareholders. Among S&P MidCap 400 director elections in 2025, support for these three directors was in the bottom 1%.<sup>3</sup>

Shareholders have spoken. We cannot afford another year of value destruction under a Board that appears determined to avoid accountability and is unwilling to act with urgency. That is why we have nominated four highly qualified candidates who can bring fresh perspectives and relevant expertise to restore investor confidence and create value for shareholders.

Our nominees, who have already taken steps to align themselves with shareholders by collectively personally purchasing more shares in recent months than the entire incumbent Board over the past nine years, are:

&nbsp;&nbsp;&nbsp;&nbsp;· **Kurt Adams,** a technology executive with more than 25 years of experience
leading and driving growth strategies for corporate payments and health benefits platforms across public companies and within a major
financial services organization.

&nbsp;&nbsp;&nbsp;&nbsp;· **Ellen Alemany,** a veteran financial services CEO with more than 45
years of industry experience and deep expertise in governance, strategy and operational execution from her numerous senior executive and
board roles.

&nbsp;&nbsp;&nbsp;&nbsp;· **Ken Cornick,** a technology and finance expert with the entrepreneurial
perspective of a founder and proven track record overseeing capital allocation and operations in the global tech sector.

&nbsp;&nbsp;&nbsp;&nbsp;· **Lauren Taylor Wolfe,** a long-term and significant shareholder representative
with extensive experience in investment management, capital allocation and corporate governance.

------

<sup>2</sup> WEX's GAAP operating margin gap versus CPAY, adjusted for net gain on dispositions, was 15.8 points in 2024, 18.2 points in 2025, and consensus expects 18.7 points in 2026. WEX's operating margin fell from 26.1% in 2024 to 25.0% in 2025, while CPAY's margin rose from 41.9% to 43.1%.

<sup>3</sup> Percentile calculated based on stockholder support in 2,936 director elections at S&P MidCap 400 companies in 2025.

By electing these nominees, shareholders will be adding to the Board independent, objective directors with the skills, experience and shareholder-aligned perspectives to help the Company realize its value potential for all stakeholders.

We look forward to engaging with our fellow shareholders in the near-term."

**<u>Full Biographies of Impactive's Nominees</u>**

**Kurt Adams**

*Kurt has directly relevant fintech, payments and HSA industry expertise and a strong track record of developing and executing successful growth strategies that we believe would be extremely additive to WEX's Board.*

&nbsp;&nbsp;&nbsp;&nbsp;· Current CEO of IPC Systems, Inc., a provider of network services and trading
communications technology for financial institutions, since 2024.

&nbsp;&nbsp;&nbsp;&nbsp;· Served as CEO of Optum Financial, Inc., a payments and financial services
subsidiary of UnitedHealth Group Inc. (NYSE: UNH), and a board member of Optum's affiliated bank from 2019 to 2024.

&nbsp;&nbsp;&nbsp;&nbsp;· Served as Group President of the Corporate Payments division of a WEX peer,
Fleetcor Technologies, Inc. (n/k/a Corpay, Inc., NYSE: CPAY), from 2015 to 2019.

**Ellen Alemany**

*Ellen has decades of executive leadership experience along with deep expertise in strategy, corporate governance and capital allocation that we believe would be highly additive to WEX's Board.*

 

&nbsp;&nbsp;&nbsp;&nbsp;· Current director of First Citizens BancShares, Inc. (NASDAQ: FCNCA) and member
of the risk committee since 2022.

&nbsp;&nbsp;&nbsp;&nbsp;· Served as chairwoman and CEO of CIT Group from 2016 to 2022, where she oversaw
a multi-year strategic transformation and merger with First Citizens.

&nbsp;&nbsp;&nbsp;&nbsp;· Served as head of management structure from 2007 to 2013 at the Royal Bank
of Scotland (RBS) Americas and chairwoman and CEO of its subsidiary, RBS Citizens Financial Group, Inc.

&nbsp;&nbsp;&nbsp;&nbsp;· Served in various roles of escalating seniority from 1987 to 2007 at Citigroup
Inc., culminating as CEO of Global Transaction Services.

&nbsp;&nbsp;&nbsp;&nbsp;· Served as a director on the boards of Fidelity National Information Services,
Inc. (NYSE: FIS), Automatic Data Processing, Inc. (NASDAQ: ADP), Dun & Bradstreet Holdings, Inc. (formerly NYSE: DNB) and as a director
on the Federal Reserve's Federal Advisory Council.

**Ken Cornick**

*Ken has strong financial acumen and extensive experience driving operational, capital allocation and profitability improvements that we believe would be extremely additive to WEX's Board.*

 

&nbsp;&nbsp;&nbsp;&nbsp;· Current director on the board of Clarivate Plc (NYSE: CLVT) since July 2025
and chair of the audit committee.

&nbsp;&nbsp;&nbsp;&nbsp;· Co-founder of Clear Secure, Inc. (NYSE: YOU) where he served in senior roles
including president, CFO and board member from 2010 to 2025.

&nbsp;&nbsp;&nbsp;&nbsp;· Served as a partner at Arience Capital, a value-oriented hedge fund investing
across a wide variety of industries, from 2003 to 2009.

**Lauren Taylor Wolfe**

*Lauren has the necessary perspective as a long-term and significant shareholder representative, as well as extensive capital allocation, corporate governance and investment expertise that we believe would be highly additive to WEX's Board.*

 

&nbsp;&nbsp;&nbsp;&nbsp;· Co-founder and managing partner of Impactive Capital, one of the largest
shareholders of WEX, since 2018.

&nbsp;&nbsp;&nbsp;&nbsp;· Served as managing director at investment firm Blue Harbour Group, leading
investments in the technology, consumer and business and healthcare services industries from 2007 to 2018.

&nbsp;&nbsp;&nbsp;&nbsp;· Served as a director on the boards of HD Supply Holdings, Inc. (formerly
NASDAQ: HDS) from 2017 until its sale in 2020, and Envestnet, Inc. (formerly NYSE: ENV) from 2023 until its merger in 2024.

**Contact:**<br> info@impactivecapital.com

Longacre Square Partners<br> impactive@longacresquare.com

**CERTAIN INFORMATION CONCERNING THE PARTICIPANTS**

Impactive Capital Master Fund LP ("Impactive Capital Master Fund"), together with the other participants named herein (collectively, "Impactive"), intend to file a preliminary proxy statement and accompanying WHITE universal proxy card with the Securities and Exchange Commission ("SEC") to be used to solicit votes for the election of Impactive's slate of highly qualified director nominees at the 2026 annual meeting of stockholders of WEX Inc., a Delaware corporation (the "Company").

IMPACTIVE STRONGLY ADVISES ALL STOCKHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS, INCLUDING A PROXY CARD, AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SEC'S WEB SITE AT HTTP://WWW.SEC.GOV. IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST. REQUESTS FOR COPIES SHOULD BE DIRECTED TO THE PARTICIPANTS' PROXY SOLICITOR.

The participants in the proxy solicitation are anticipated to be Impactive Capital Master Fund, Impactive Sierra Fund LP ("Impactive Sierra"), Impactive Zephyr Fund LP ("Impactive Zephyr" and together with Impactive Capital Master Fund and Impactive Sierra, the "Impactive Funds"), Impactive Capital LP ("Impactive Capital"), Impactive Capital LLC ("Impactive Capital GP"), Christian Asmar, Lauren Taylor Wolfe, Alemany October 2025 GRAT No. 1 ("Alemany Trust"), Cornick Family Investor, LLC ("Cornick Family Investor"), Kurt P. Adams, Ellen R. Alemany and Kenneth L. Cornick.

As of the date hereof, Impactive Capital Master Fund holds 1,341,381 shares of common stock, $0.01 par value per share, of the Company (the "Common Stock"). As of the date hereof, Impactive Sierra holds 313,261 shares of Common Stock. As of the date hereof, Impactive Zephyr holds 52,611 shares of Common Stock. Impactive Capital, as the investment manager of the Impactive Funds, may be deemed to beneficially own the 1,707,253 shares of Common Stock held by the Impactive Funds. Impactive Capital GP, as the general partner of Impactive Capital, may be deemed to beneficially own the 1,707,253 shares of Common Stock held by the Impactive Funds. Each of Mr. Asmar and Ms. Taylor Wolfe, as managing members of Impactive Capital GP, may be deemed to beneficially own the 1,707,253 shares of Common Stock held by the Impactive Funds. As of the date hereof, Alemany Trust directly beneficially owns 6,000 shares of Common Stock. Ms. Alemany, as trustee of Alemany Trust, may be deemed to beneficially own the 6,000 shares of Common Stock directly beneficially owned by Alemany Trust. As of the date hereof, Cornick Family Investor directly beneficially owns 7,000 shares of Common Stock. Mr. Cornick, as the manager of Cornick Family Investor, may be deemed to beneficially own the 7,000 shares of Common Stock directly beneficially owned by Cornick Family Investor. As of the date hereof, Mr. Adams does not beneficially own any shares of Common Stock.

## Exhibit 99.2

Exhibit 99.2

**<u>AMENDED AND RESTATED GROUP AGREEMENT</u>**

WHEREAS, certain of the undersigned are stockholders, direct or beneficial, of WEX Inc., a Delaware corporation (the "<u>Company</u>");

WHEREAS, certain of the undersigned are parties to that certain Group Agreement, dated October 20, 2025 (the "<u>Original Group Agreement</u>"), for the purpose of, among other things, coordinating their activities with respect to the Company;

WHEREAS, Impactive Capital Master Fund LP, Impactive Sierra Fund LP, Impactive Zephyr Fund LP, Impactive Capital LP, Impactive Capital LLC, Christian Asmar and Lauren Taylor Wolfe (collectively, "<u>Impactive</u>"), Kurt Adams, Ellen R. Alemany and Kenneth L. Cornick (collectively, the "<u>External Nominees</u>"), Alemany October 2025 GRAT No. 1 and Cornick Family Investor, LLC wish to enter into this Amended and Restated Group Agreement (this "<u>Agreement</u>") to supersede and amend and restate the Original Group Agreement in its entirety; and

WHEREAS, each of the undersigned (collectively, the "<u>Group</u>") wish to form a group for the purpose of (i) seeking representation on the Board of Directors of the Company (the "<u>Board</u>") at the 2026 annual meeting of stockholders of the Company (including any other meeting of stockholders held in lieu thereof, and any adjournments, postponements, reschedulings or continuations thereof, the "<u>Annual Meeting</u>"), (ii) soliciting proxies for the election of certain persons nominated for election to the Board at the Annual Meeting (including those nominated by or on behalf of Impactive), (iii) taking all other action necessary to achieve the foregoing and (iv) taking any other actions the Group (as defined below) determines to undertake in connection with their respective investment in the Company (collectively, the "<u>Purposes</u>").

NOW, IT IS AGREED, this 9th day of February 2026 by the Parties hereto:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Original Group Agreement is hereby superseded in its entirety and shall be of no further force or effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended (the "<u>Exchange Act</u>"), each of the undersigned agrees to the joint filing on behalf of each of them of statements on Schedule 13D, and any amendments thereto, with respect to the securities of the Company. Each member of the Group shall be responsible for the accuracy and completeness of his/her/its own disclosure therein, and is not responsible for the accuracy and completeness of the information concerning the other members, unless such member knows or has reason to know that such information is inaccurate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. So long as this Agreement is in effect, each of the undersigned shall provide written notice to Olshan Frome Wolosky LLP ("<u>Olshan</u>"), such notice to be given no later than 24 hours after each such transaction, of (i) any of their purchases or sales of securities of the Company or (ii) any securities of the Company over which they acquire or dispose of beneficial ownership. For purposes of this Agreement, the term "beneficial ownership" shall have the meaning of such term set forth in Rule 13d-3 under the Exchange Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. So long as this Agreement is in effect, each of the External Nominees agrees to provide Impactive advance written notice prior to effecting any purchase, sale, acquisition or disposition of any securities of the Company which he or she has, or would have, direct or indirect beneficial ownership so that Impactive has an opportunity to review the potential implications of any such transaction in the securities of the Company and pre-clear any such potential transaction in the securities of the Company by any of the External Nominees. Each of the External Nominees agrees that he or she shall not undertake or effect any purchase, sale, acquisition or disposition of any securities of the Company without the prior written consent of Impactive.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. Each of the undersigned agrees to form the Group for the Purposes as set forth above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. Impactive shall have the right to pre-approve all expenses incurred in connection with the Group's activities and agrees to pay directly all such pre-approved expenses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. Each of the undersigned agrees that any filing with the Securities and Exchange Commission, press release or other communication proposed to be made or issued by the Group or any member of the Group in connection with the Group's activities set forth in Section 5 shall be as directed by Impactive.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. The relationship of the parties hereto shall be limited to carrying on the business of the Group in accordance with the terms of this Agreement. Such relationship shall be construed and deemed to be for the sole and limited purpose of carrying on such business as described herein. Nothing herein shall be construed to authorize any party to act as an agent for any other party, or to create a joint venture or partnership, or to constitute an indemnification. Nothing herein shall restrict any party's right to purchase or sell securities of the Company, as he/it deems appropriate, in his, her or its sole discretion, provided that all such sales are made in compliance with all applicable securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which, taken together, shall constitute but one and the same instrument, which may be sufficiently evidenced by one counterpart.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. This Agreement is governed by and will be construed in accordance with the laws of the State of New York. In the event of any dispute arising out of the provisions of this Agreement or their investment in the Company, the parties hereto consent and submit to the exclusive jurisdiction of the Federal and State Courts in the State of New York.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. Any party hereto may terminate his/her/its obligations under this Agreement on 24 hours' written notice to all other parties, with a copy by fax to Andrew M. Freedman at Olshan, Fax No. (212) 451-2222.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. Each of the undersigned acknowledges that Olshan shall act as counsel for both the Group and Impactive relating to their investment in the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. Each of the undersigned parties hereby agrees that this Agreement shall be filed as an exhibit to any Schedule 13D required to be filed under applicable law pursuant to Rule 13d-1(k)(1)(iii) under the Exchange Act.

[Signature page follows]

IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed as of the day and year first above written.

---

| | |
|:---|:---|
| **IMPACTIVE CAPITAL MASTER FUND LP** | **IMPACTIVE CAPITAL MASTER FUND LP** |
| By: | Impactive Capital GP LLC |
|  | its General Partner |
| By: | /s/ Lauren Taylor Wolfe |
|  | Name: Lauren Taylor Wolfe |
|  | Title: Managing Member |
| **IMPACTIVE SIERRA FUND LP** | **IMPACTIVE SIERRA FUND LP** |
| By: | Impactive Capital GP LLC |
|  | its General Partner |
| By: | /s/ Lauren Taylor Wolfe |
|  | Name: Lauren Taylor Wolfe |
|  | Title: Managing Member |
| **IMPACTIVE ZEPHYR FUND LP** | **IMPACTIVE ZEPHYR FUND LP** |
| By: | Impactive Capital GP LLC<br> its General Partner |
| By: | /s/ Lauren Taylor Wolfe |
|  | Name: Lauren Taylor Wolfe |
|  | Title: Managing Member |
| **IMPACTIVE CAPITAL LP** | **IMPACTIVE CAPITAL LP** |
| By: | Impactive Capital LLC |
|  | its General Partner |
| By: | /s/ Lauren Taylor Wolfe |
|  | Name: Lauren Taylor Wolfe |
|  | Title: Managing Member |
| **IMPACTIVE CAPITAL LLC** | **IMPACTIVE CAPITAL LLC** |
| By: | /s/ Lauren Taylor Wolfe |
|  | Name: Lauren Taylor Wolfe |
|  | Title: Managing Member |

---

---

| |
|:---|
| /s/ Lauren Taylor Wolfe |
| Lauren Taylor Wolfe |

---

---

| |
|:---|
| /s/ Christian Asmar |
| Christian Asmar |
| /s/ Kurt Adams |
| Kurt Adams |

---

---

| |
|:---|
| /s/ Ellen R. Alemany |
| Ellen R. Alemany |

---

---

| | |
|:---|:---|
| **Alemany October 2025 GRAT No. 1** | **Alemany October 2025 GRAT No. 1** |
| By: | /s/ Ellen R. Alemany |
|  | Name: Ellen R. Alemany |
|  | Title: Trustee |

---

---

| |
|:---|
| /s/ Kenneth L. Cornick |
| Kenneth L. Cornick |

---

---

| | |
|:---|:---|
| **Cornick Family Investor, LLC** | **Cornick Family Investor, LLC** |
| By: | /s/ Kenneth L. Cornick |
|  | Name: Kenneth L. Cornick |
|  | Title: Manager |

---

## Exhibit 99.3

Exhibit 99.3

**IMPACTIVE CAPITAL MASTER FUND LP**<br> **c/o IMPACTIVE CAPITAL LP**<br> **450 W 14th St, 12th Floor**<br> **New York, New York 10014**<br>

____________, 2026

**Re: WEX Inc.**

Dear [Nominee]:

Thank you for agreeing to serve as a nominee for election to the Board of Directors of WEX Inc. (the "Company") in connection with the proxy solicitation that Impactive Capital Master Fund LP and certain of its affiliates (collectively, the "Impactive Group") is considering undertaking to nominate and elect directors at the Company's 2026 annual meeting of stockholders, or any other meeting of stockholders held in lieu thereof, and any adjournments, postponements, reschedulings or continuations thereof (the "Impactive Group Solicitation"). Your outstanding qualifications, we believe, will prove a valuable asset to the Company and all of its stockholders. This letter (this "Agreement") will set forth the terms of our agreement.

The members of the Impactive Group agree to jointly and severally indemnify and hold you harmless against any and all claims of any nature, whenever brought, arising from the Impactive Group Solicitation and any related transactions, irrespective of the outcome; <u>provided</u>, <u>however</u>, that you will not be entitled to indemnification for claims arising from your gross negligence, willful misconduct, intentional and material violations of law, criminal actions, provision to the Impactive Group of false or misleading information (including false or misleading information on any questionnaire you are requested to complete by the Impactive Group or the Company) or material breach of the terms of this Agreement; <u>provided further</u>, that upon your becoming a director of the Company, this indemnification shall not apply to any claims made against you in your capacity as a director of the Company. This indemnification will include any and all losses, liabilities, damages, demands, claims, suits, actions, judgments, or causes of action, assessments, costs and expenses, including, without limitation, interest, penalties, reasonable attorneys' fees, and any and all reasonable costs and expenses incurred in investigating, preparing or defending against any litigation, commenced or threatened, any civil, criminal, administrative or arbitration action, or any claim whatsoever, and any and all amounts paid in settlement of any claim or litigation asserted against, resulting, imposed upon, or incurred or suffered by you, directly or indirectly, as a result of or arising from the Impactive Group Solicitation and any related transactions (each, a "Loss").

In the event of a claim against you pursuant to the prior paragraph or the occurrence of a Loss, you shall give the Impactive Group prompt written notice of such claim or Loss (provided that failure to promptly notify the Impactive Group shall not relieve us from any liability which we may have on account of this Agreement, except to the extent we shall have been materially prejudiced by such failure). Upon receipt of such written notice, the Impactive Group will provide you with counsel to represent you. Such counsel shall be reasonably acceptable to you. In addition, you will be reimbursed promptly for all Losses suffered by you and as incurred as provided herein. The Impactive Group may not enter into any settlement of loss or claim without your consent unless such settlement includes a release of you from any and all liability in respect of such claim.

You hereby agree to keep confidential and not disclose to any party, without the consent of the Impactive Group, any confidential, proprietary or non-public information (collectively, "Information") of the Impactive Group or its affiliates which you have heretofore obtained or may obtain in connection with your service as a nominee hereunder. Notwithstanding the foregoing, Information shall not include any information that is publicly disclosed by the Impactive Group or its affiliates or any information that you can demonstrate is now, or hereafter becomes, through no act or failure to act on your part, otherwise generally known to the public.

Notwithstanding the foregoing, if you are required by applicable law, rule, regulation or legal process to disclose any Information you may do so provided that you first promptly notify the Impactive Group so that the Impactive Group or any member thereof may seek a protective order or other appropriate remedy or, in the Impactive Group's sole discretion, waive compliance with the terms of this Agreement. In the event that no such protective order or other remedy is obtained or the Impactive Group does not waive compliance with the terms of this Agreement, you may consult with counsel at the cost of the Impactive Group and you may furnish only that portion of the Information which you are advised by counsel is legally required to be so disclosed and you will request that the party(ies) receiving such Information maintain it as confidential. The confidentiality restrictions set forth in this Agreement shall not (a) apply (i) to any compelled testimony or production of information, whether by legal process, subpoena, or as part of a response to a request for information from any governmental or regulatory authority with jurisdiction over you, in each case to the extent required, or (ii) to any disclosure that you reasonably believe, after consultation with outside counsel, to be legally required by applicable law, rules or regulations, in each case of clause (i) or (ii), solely to the extent that such restrictions would require a violation of the applicable requirement; or (b) prohibit you from reporting what you reasonably believe, after consultation with outside counsel, to be violations of federal law or regulation to any governmental authority pursuant to Section 21F of the Exchange Act or Rule 21F promulgated thereunder.

All Information, all copies thereof, and any studies, notes, records, analysis, compilations or other documents prepared by you containing such Information, shall be and remain the property of the Impactive Group and, upon the request of a representative of the Impactive Group, all such Information shall be returned or, at the Impactive Group's option, destroyed by you, with such destruction confirmed by you to the Impactive Group in writing.

This Agreement shall be governed by the laws of the State of New York, without regard to the principles of the conflicts of laws thereof.

**\* \* \***

If you agree to the foregoing terms, please sign below to indicate your acceptance.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **IMPACTIVE CAPITAL MASTER FUND LP** | **IMPACTIVE CAPITAL MASTER FUND LP** |
| By: | Impactive Capital GP LLC |
|  | its General Partner |
| By: |  |
|  | Name: Lauren Taylor Wolfe |
|  | Title: Managing Member |

---

**ACCEPTED AND AGREED:**

 **________________________**

[NOMINEE]

## Exhibit 99.4

Exhibit 99.4

**<u>POWER OF ATTORNEY</u>**

Know all by these presents, that the undersigned hereby constitutes and appoints Lauren Taylor Wolfe the undersigned's true and lawful attorney-in-fact to take any and all action in connection with (i) the undersigned's beneficial ownership of, or participation in a group with respect to, securities of WEX Inc., a Delaware corporation (the "Company"), directly or indirectly beneficially owned by Impactive Capital Master Fund LP or any of its affiliates or members of its group (as such term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) (collectively, the "Group") and (ii) any proxy solicitation that may be pursued by the Group to elect the Group's slate of director nominees to the board of directors of the Company at the 2026 annual meeting of stockholders of the Company, including any adjournments or postponements thereof (the "Solicitation"). Such action shall include, but not be limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. if applicable, executing for and on behalf of the undersigned any Schedule 13D, and amendments thereto, filed by the Group that are required to be filed under Section 13(d) of the Exchange Act, and the rules thereunder in connection with the undersigned's beneficial ownership of, or participation in a group with respect to, securities of the Company or the Solicitation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. if applicable, executing for and on behalf of the undersigned all Forms 3, 4 and 5 required to be filed under Section 16(a) of the Exchange Act and the rules thereunder in connection with the undersigned's beneficial ownership of, or participation in a group with respect to, securities of the Company or the Solicitation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. executing for and on behalf of the undersigned all Group Agreements or similar documents pursuant to which the undersigned shall agree to be a member of the Group;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. performing any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such document, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. taking any other action of any type whatsoever in connection with the Solicitation, including entering into any settlement agreement, that in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming any of the undersigned's responsibilities to comply with Section 13(d), Section 16 or Section 14 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer a member of the Group unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 9th day of February 2026.

---

| |
|:---|
| /s/ Kurt Adams |
| **KURT ADAMS** |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 5)**

**WEX Inc.**

*(Name of Issuer)*

**Common Stock, $0.01 par value per share**

*(Title of Class of Securities)*

**96208T104**

*(CUSIP Number)*

**CHRISTIAN ASMAR**<br>IMPACTIVE CAPITAL LP<br>450 West 14th Street, 12th Floor<br>New York NY 10014<br>212-218-8810

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**02/06/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **96208T104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Impactive Capital LP** | Name of reporting person<br>**Impactive Capital LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1707253.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1707253.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1707253.00** | Aggregate amount beneficially owned by each reporting person<br>**1707253.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**5.0%** | Percent of class represented by amount in Row (11)<br>**5.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

| **CUSIP No.** | **96208T104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Impactive Capital LLC** | Name of reporting person<br>**Impactive Capital LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1707253.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1707253.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1707253.00** | Aggregate amount beneficially owned by each reporting person<br>**1707253.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**5.0%** | Percent of class represented by amount in Row (11)<br>**5.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

| **CUSIP No.** | **96208T104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Wolfe Lauren Taylor** | Name of reporting person<br>**Wolfe Lauren Taylor** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1707253.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1707253.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1707253.00** | Aggregate amount beneficially owned by each reporting person<br>**1707253.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**5.0%** | Percent of class represented by amount in Row (11)<br>**5.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **96208T104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Asmar Christian** | Name of reporting person<br>**Asmar Christian** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1707253.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1707253.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1707253.00** | Aggregate amount beneficially owned by each reporting person<br>**1707253.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**5.0%** | Percent of class represented by amount in Row (11)<br>**5.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **96208T104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Kurt P. Adams** | Name of reporting person<br>**Kurt P. Adams** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**0.00** | Aggregate amount beneficially owned by each reporting person<br>**0.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **96208T104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Ellen R. Alemany** | Name of reporting person<br>**Ellen R. Alemany** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**6000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**6000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6000.00** | Aggregate amount beneficially owned by each reporting person<br>**6000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **96208T104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Alemany October 2025 GRAT No. 1** | Name of reporting person<br>**Alemany October 2025 GRAT No. 1** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**NEW YORK** | Citizenship or place of organization<br>**NEW YORK** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**6000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**6000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6000.00** | Aggregate amount beneficially owned by each reporting person<br>**6000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

| **CUSIP No.** | **96208T104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Kenneth L. Cornick** | Name of reporting person<br>**Kenneth L. Cornick** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**7000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**7000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7000.00** | Aggregate amount beneficially owned by each reporting person<br>**7000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **96208T104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Cornick Family Investor, LLC** | Name of reporting person<br>**Cornick Family Investor, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**NEW YORK** | Citizenship or place of organization<br>**NEW YORK** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**7000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**7000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7000.00** | Aggregate amount beneficially owned by each reporting person<br>**7000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, $0.01 par value per share

**(b) Name of Issuer:**
WEX Inc.

**(c) Address of Issuer's Principal Executive Offices:**
1 HANCOCK STREET, PORTLAND, ME, 04101

**Item 4. Purpose of Transaction**

Item 4 is hereby amended to add the following:

On February 9, 2026, Impactive Capital Master Fund LP, an affiliate of Impactive Capital (together with its affiliates, "Impactive"), delivered a letter to the Issuer nominating its finalized slate of highly qualified director candidates, including Kurt P. Adams, Ellen R. Alemany, Kenneth L. Cornick, and Lauren Taylor Wolfe (collectively, the "Nominees"), for election to the Board at the Issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"). As evidenced by their biographies below, the Nominees have extensive experience in global financial technology, executive leadership, public company governance and operations, and are well qualified to serve on the Board.

Also on February 9, 2026, Impactive issued a press release (the "Press Release") announcing that it had nominated the Nominees for election to the Board at the 2026 Annual Meeting. In the Press Release, Impactive reiterated its concerns with the Issuer's inability to close the gap between the Issuer's intrinsic value and its stock price, unwillingness to hold management accountable, and general disregard for shareholder views. A copy of the Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The Nominees are:

Kurt Adams
- A technology executive with more than 25 years of experience leading and driving growth strategies for corporate payments and health benefits platforms across public companies and within a major financial services organization.
- Current CEO of IPC Systems, Inc., a provider of network services and trading communications technology for financial institutions, since 2024.
- Served as CEO of Optum Financial, Inc., a payments and financial services subsidiary of UnitedHealth Group Inc. (NYSE: UNH), and a board member of Optum's affiliated bank from 2019 to 2024.
- Served as Group President of the Corporate Payments division of a WEX peer, Fleetcor Technologies, Inc. (n/k/a Corpay, Inc., NYSE: CPAY), from 2015 to 2019.

Ellen Alemany
- A veteran financial services CEO with more than 45 years of industry experience and deep expertise in governance, strategy and operational execution from her numerous senior executive and board roles.
- Current director of First Citizens BancShares, Inc. (NASDAQ: FCNCA) and member of the risk committee since 2022.
- Served as chairwoman and CEO of CIT Group from 2016 to 2022, where she oversaw a multi-year strategic transformation and merger with First Citizens.
- Served as head of management structure from 2007 to 2013 at The Royal Bank of Scotland (RBS) Americas and chairwoman and CEO of its subsidiary, RBS Citizens Financial Group, Inc.
- Served in various roles of escalating seniority from 1987 to 2007 at Citigroup Inc., culminating as CEO of Global Transaction Services.
- Served as a director on the boards of Fidelity National Information Services, Inc. (NYSE: FIS), Automatic Data Processing, Inc. (NASDAQ: ADP), Dun & Bradstreet Holdings, Inc. (formerly NYSE: DNB) and as a director on the Federal Reserve's Federal Advisory Council.

Ken Cornick
- A technology and finance expert with the entrepreneurial perspective of a founder and proven track record overseeing capital allocation and operations in the global tech sector.
- Current director on the board of Clarivate Plc (NYSE: CLVT) since July 2025 and chair of the audit committee.
- Co-founder of Clear Secure, Inc. (NYSE: YOU) where he served in senior roles including president, CFO, and board member from 2010 to 2025.
- Served as a partner at Arience Capital, a value-oriented hedge fund focused on consumer, tech, and aerospace sectors, from 2003 to 2009.

Lauren Taylor Wolfe
- A long-term and significant shareholder representative with extensive experience in investment management, capital allocation and corporate governance.
- Co-founder and managing partner of Impactive Capital, one of the largest shareholders of WEX, since 2018.
- Served as managing director at investment firm Blue Harbour Group, leading investments in the technology, consumer and business and healthcare services industries from 2007 to 2018.
- Served as a director on the boards of HD Supply Holdings, Inc. (formerly NASDAQ: HDS) from 2017 until its sale in 2020, and Envestnet, Inc. (formerly NYSE: ENV) from 2023 until its merger in 2024.

The sales of Shares reported herein were undertaken for the purposes of effectuating a portfolio rebalancing and are not an indication of the Reporting Persons' view on the future prospects of the Issuer.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5(a) is hereby amended and restated as follows:

The aggregate percentage of Shares reported beneficially owned by the Reporting Persons is based upon 34,288,525 Shares outstanding as of October 23, 2025, which is the total number of Shares outstanding as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on October 30, 2025.

A. Impactive Capital
As of the date hereof, Impactive Capital beneficially owned 1,707,253 Shares held by the Impactive Funds.
Percentage: Approximately 5.0%

B. Impactive Capital GP
Impactive Capital GP, as the general partner of Impactive Capital, may be deemed to beneficially own the 1,707,253 Shares beneficially owned by Impactive Capital.
Percentage: Approximately 5.0%

C. Ms. Taylor Wolfe
Ms. Taylor Wolfe, as a Managing Member of Impactive Capital GP, may be deemed to beneficially own the 1,707,253 Shares beneficially owned by Impactive Capital.
Percentage: Approximately 5.0%

D. Mr. Asmar
Mr. Asmar, as a Managing Member of Impactive Capital GP, may be deemed to beneficially own the 1,707,253 Shares beneficially owned by Impactive Capital.
Percentage: Approximately 5.0%

E. Mr. Adams
As of the date hereof, Mr. Adams beneficially owned 0 Shares.
Percentage: 0%

F. Ms. Alemany
Ms. Alemany, as trustee of Alemany Trust, may be deemed to beneficially own the 6,000 Shares beneficially owned by Alemany Trust.
Percentage: Less than 1%

G. Alemany Trust
As of the date hereof, Alemany Trust beneficially owned 6,000 Shares.
Percentage: Less than 1%

H. Mr. Cornick
Mr. Cornick, as a manager of Cornick Family Investor with his spouse, may be deemed to beneficially own the 7,000 Shares beneficially owned by Cornick Family Investor.
Percentage: Less than 1%

I. Cornick Family Investor
As of the date hereof, Cornick Family Investor beneficially owned 7,000 Shares.
Percentage: Less than 1%

Each Reporting Person may be deemed to be a member of a "group" with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, and such group may be deemed to beneficially own the 1,720,253 Shares owned in the aggregate by all of the Reporting Persons, constituting approximately 5.02% of the Shares outstanding. Each Reporting Person disclaims beneficial ownership of the Shares that he, she or it does not directly own.

**(b)**
Item 5(b) is hereby amended and restated as follows:

Impactive Capital:
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 1,707,253
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 1,707,253

Impactive Capital GP:
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 1,707,253
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 1,707,253

Ms. Taylor Wolfe:
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 1,707,253
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 1,707,253

Mr. Asmar:
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 1,707,253
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 1,707,253

Mr. Adams:
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 0

Ms. Alemany:
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 6,000
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 6,000

Alemany Trust:
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 6,000
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 6,000

Mr. Cornick:
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 7,000
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 7,000

Cornick Family Investor:
1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 7,000
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 7,000

**(c)**
Item 5(c) is hereby amended and restated as follows:

The transactions in the Shares by the Reporting Persons during the past sixty days are set forth in Exhibit 1 and are incorporated herein by reference.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 6 is hereby amended to add the following:

On February 9, 2026, Impactive and the Nominees (collectively, the "Group") entered into an Amended and Restated Group Agreement (the "Amended and Restated Group Agreement") with respect to the Issuer pursuant to which, among other things, (a) that certain group agreement, dated October 20, 2025, by and among certain of the Reporting Persons and other third parties was superseded in its entirety, (b) the Group agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer, (c) the Group agreed to solicit proxies for the election of the Nominees at the 2026 Annual Meeting, (c) each of the Nominees (other than Ms. Taylor Wolfe) agreed that he or she will not undertake or effect any purchase, sale, acquisition or disposition of any securities of the Issuer without the prior written consent of Impactive and (d) Impactive shall have the right to pre-approve all expenses incurred in connection with the Group's activities and agrees to pay directly all such pre-approved expenses. The Amended and Restated Group Agreement is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

Impactive has signed separate letter agreements (the "Indemnification Agreements") with each of the Nominees (other than Ms. Taylor Wolfe), pursuant to which it has agreed to indemnify such Nominees against certain claims arising from the solicitation of proxies from the Issuer's stockholder in connection with the 2026 Annual Meeting and any related transactions. For the avoidance of doubt, such indemnification does not apply to any claims made against the Nominees in their capacity as a director of the Issuer, if so elected. A form of the Indemnification Agreement is attached hereto as Exhibit 99.3 and is incorporated herein by reference.

Impactive has entered into a Compensation Agreement (as previously defined and described in Amendment No. 4 to the Schedule 13D) with Mr. Adams. A form of the Compensation Agreement was attached as Exhibit 99.2 to Amendment No. 4 to the Schedule 13D and is incorporated herein by reference.

Mr. Adams has granted Ms. Taylor Wolfe a power of attorney to execute certain SEC filings and other documents, as necessary, in connection with the solicitation of proxies at the 2026 Annual Meeting. Such Power of Attorney is attached hereto as Exhibit 99.4 and is incorporated herein by reference.

The previously disclosed Compensation Agreements entered into between Impactive and each of Messrs. Fox and Saxena, and the previously disclosed Powers of Attorney (as previously defined and described in Amendment No. 4 to the Schedule 13D) granted by Messrs. Fox and Saxena to Ms. Taylor Wolfe, were terminated pursuant to their terms.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Impactive Capital LP

**Signature:** /s/ Lauren Taylor Wolfe

**Name/Title:** Lauren Taylor Wolfe, Managing Member of Impactive Capital LLC, its General Partner

**Date:** 02/09/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Impactive Capital LLC

**Signature:** /s/ Lauren Taylor Wolfe

**Name/Title:** Lauren Taylor Wolfe, Managing Member

**Date:** 02/09/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Wolfe Lauren Taylor

**Signature:** /s/ Lauren Taylor Wolfe

**Name/Title:** Lauren Taylor Wolfe

**Date:** 02/09/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Asmar Christian

**Signature:** /s/ Christian Asmar

**Name/Title:** Asmar Christian

**Date:** 02/09/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Kurt P. Adams

**Signature:** /s/ Lauren Taylor Wolfe

**Name/Title:** Lauren Taylor Wolfe, Attorney-in-Fact for Kurt Adams

**Date:** 02/09/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Ellen R. Alemany

**Signature:** /s/ Lauren Taylor Wolfe

**Name/Title:** Lauren Taylor Wolfe, Attorney-in-Fact for Ellen R. Alemany

**Date:** 02/09/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Alemany October 2025 GRAT No. 1

**Signature:** /s/ Ellen R. Alemany

**Name/Title:** Ellen R. Alemany, Trustee

**Date:** 02/09/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Kenneth L. Cornick

**Signature:** /s/ Lauren Taylor Wolfe

**Name/Title:** Lauren Taylor Wolfe, Attorney-in-Fact for Kenneth L. Cornick

**Date:** 02/09/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Cornick Family Investor, LLC

**Signature:** /s/ Kenneth L. Cornick

**Name/Title:** Kenneth L. Cornick, Manager

**Date:** 02/09/2026